A detailed history of Ubs Asset Management Americas Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 2,163,487 shares of TMO stock, worth $1.14 Billion. This represents 0.35% of its overall portfolio holdings.

Number of Shares
2,163,487
Previous 2,143,951 0.91%
Holding current value
$1.14 Billion
Previous $1.19 Billion 12.87%
% of portfolio
0.35%
Previous 0.34%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$531.86 - $624.21 $10.4 Million - $12.2 Million
19,536 Added 0.91%
2,163,487 $1.34 Billion
Q2 2024

Aug 13, 2024

BUY
$541.52 - $599.02 $303 Million - $336 Million
560,278 Added 35.38%
2,143,951 $1.19 Billion
Q1 2024

May 15, 2024

SELL
$528.82 - $599.43 $14.7 Million - $16.7 Million
-27,796 Reduced 1.72%
1,583,673 $920 Million
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $41.7 Million - $51.5 Million
-96,635 Reduced 5.66%
1,611,469 $855 Million
Q3 2023

Nov 13, 2023

BUY
$498.29 - $574.41 $29.4 Million - $33.9 Million
58,966 Added 3.58%
1,708,104 $865 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $116 Million - $131 Million
-216,825 Reduced 11.62%
1,649,138 $951 Million
Q4 2022

Feb 14, 2023

SELL
$484.71 - $571.37 $1.8 Million - $2.12 Million
-3,709 Reduced 0.2%
1,865,963 $1.03 Billion
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $131 Million - $156 Million
-257,334 Reduced 12.1%
1,869,672 $948 Million
Q2 2022

Aug 12, 2022

BUY
$500.9 - $612.21 $90.9 Million - $111 Million
181,476 Added 9.33%
2,127,006 $1.16 Billion
Q1 2022

May 16, 2022

SELL
$524.0 - $644.92 $83.4 Million - $103 Million
-159,067 Reduced 7.56%
1,945,530 $1.15 Billion
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $431 Million - $505 Million
-756,885 Reduced 26.45%
2,104,597 $1.4 Billion
Q3 2021

Nov 15, 2021

BUY
$509.53 - $609.78 $227 Million - $272 Million
445,902 Added 18.46%
2,861,482 $1.63 Billion
Q2 2021

Aug 16, 2021

BUY
$441.0 - $508.24 $61.9 Million - $71.4 Million
140,393 Added 6.17%
2,415,580 $1.22 Billion
Q1 2021

May 14, 2021

BUY
$439.85 - $518.83 $20 Million - $23.6 Million
45,448 Added 2.04%
2,275,187 $1.04 Billion
Q4 2020

Mar 01, 2021

SELL
$435.06 - $527.66 $268 Million - $326 Million
-617,042 Reduced 21.68%
2,229,739 $1.04 Billion
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $10.4 Million - $12.8 Million
-29,034 Reduced 1.01%
2,846,781 $1.26 Billion
Q2 2020

Aug 14, 2020

SELL
$275.2 - $362.34 $16.3 Million - $21.5 Million
-59,205 Reduced 2.02%
2,875,815 $1.04 Billion
Q1 2020

May 15, 2020

BUY
$255.3 - $340.05 $44.2 Million - $58.8 Million
173,018 Added 6.26%
2,935,020 $832 Million
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $53.6 Million - $64.7 Million
-197,109 Reduced 6.66%
2,762,002 $897 Million
Q3 2019

Nov 14, 2019

BUY
$268.46 - $305.43 $224 Million - $255 Million
835,346 Added 39.33%
2,959,111 $862 Million
Q2 2019

Aug 15, 2019

SELL
$257.51 - $295.55 $11.9 Million - $13.7 Million
-46,291 Reduced 2.13%
2,123,765 $0
Q1 2019

May 14, 2019

BUY
$212.17 - $273.72 $10.6 Million - $13.7 Million
50,078 Added 2.36%
2,170,056 $0
Q4 2018

Feb 13, 2019

BUY
$208.47 - $251.98 $5.62 Million - $6.79 Million
26,961 Added 1.29%
2,119,978 $474 Million
Q3 2018

Nov 14, 2018

BUY
$205.57 - $244.32 $5 Million - $5.94 Million
24,301 Added 1.17%
2,093,017 $0
Q2 2018

Aug 14, 2018

BUY
$203.14 - $219.53 $38.1 Million - $41.1 Million
187,324 Added 9.96%
2,068,716 $0
Q1 2018

May 14, 2018

BUY
$192.98 - $224.11 $19.3 Million - $22.5 Million
100,210 Added 5.63%
1,881,392 $0
Q4 2017

Feb 09, 2018

BUY
$182.03 - $200.37 $2.12 Million - $2.33 Million
11,625 Added 0.66%
1,781,182 $0
Q3 2017

Nov 13, 2017

BUY
$171.74 - $194.04 $304 Million - $343 Million
1,769,557
1,769,557 $0

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $207B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.